1. From the Centro Nacional de Investigaciones Oncológicas, Molecular Pathology Program, Madrid, Spain; the Pathology Department, Hospital Universitario de Getafe, Madrid, Spain; the Department of Hematology and the Institute for Molecular Medicine, St James Hospital, Dublin, Ireland; and the Dermatology and Pathology Department, Hospital 12 de Octubre, Madrid, Spain, representing the Cooperative Cutaneous Lymphoma Group of Madrid